DexCom
DXCM
#949
Rank
A$36.11 B
Marketcap
A$93.60
Share price
2.23%
Change (1 day)
-30.52%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2026 (TTM): A$1.82 Billion

According to DexCom's latest financial reports the company's current earnings are A$4.81 Billion. In 2025 the company made an earning of A$1.55 Billion, an increase over its 2024 earnings that were of A$1.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$1.82 B17.08%
2025 A$1.55 B52.02%
2024 A$1.02 B-0.37%
2023 A$1.02 B78.13%
2022 A$0.57 B47.34%
2021 A$0.39 B-10.11%
2020 A$0.43 B88.27%
2019 A$0.23 B-258.48%
2018 -A$0.15 Billion189.94%
2017 -A$50.36 Million-44.24%
2016 -A$90.31 Million12.43%
2015 -A$80.32 Million165.58%
2014 -A$30.25 Million-25.61%
2013 -A$40.66 Million-48.11%
2012 -A$78.35 Million24.5%
2011 -A$62.93 Million
2008 -A$74.31 Million13.18%
2007 -A$65.66 Million-5.36%
2006 -A$69.38 Million52.08%
2005 -A$45.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.54 B 2,028.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.44 B 566.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$8.82 B 414.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
A$2.76 B 61.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
A$1.81 B 5.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.29 Billion-116.41%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-A$1.6 Billion-193.11%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
A$0.94 B-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA